| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/12/2013 | WO2013131424A1 4-quinazoline amine derivative and application thereof |
| 09/12/2013 | WO2013131235A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof |
| 09/12/2013 | WO2013112959A8 Antifibrotic compounds and uses thereof |
| 09/12/2013 | WO2013043232A8 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer |
| 09/12/2013 | WO2007024945A8 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 09/12/2013 | US20130237538 Kinase inhibitors |
| 09/12/2013 | US20130237537 Method of treating conditiions with kinase inhibitors |
| 09/12/2013 | US20130237535 Fatty acid synthase inhibitors |
| 09/12/2013 | US20130237531 Compounds and methods for kinase modulation, and indications therefor |
| 09/12/2013 | US20130237524 Synthesis of polycyclic alkaloids |
| 09/12/2013 | US20130237523 Acrylamide derivatives as fab i inhibitors |
| 09/12/2013 | US20130237522 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 09/12/2013 | US20130237521 Imidazopyrizine syk inhibitors |
| 09/12/2013 | US20130237519 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| 09/12/2013 | US20130237518 Novel compounds that are erk inhibitors |
| 09/12/2013 | US20130237516 Azaindoles useful as inhibitors of janus kinases |
| 09/11/2013 | EP2635580A2 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |
| 09/11/2013 | EP2635579A1 Synthetic lethality in cancer |
| 09/11/2013 | EP2635578A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
| 09/11/2013 | EP2635577A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof |
| 09/11/2013 | EP2635576A1 Benzyl-substituted carbamates and use thereof |
| 09/11/2013 | EP2635575A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| 09/11/2013 | EP2635574A1 1h-pyrrolo[2,3-b]pyridine derivatives |
| 09/11/2013 | EP2635557A2 Nicotinamides as jak kinase modulators |
| 09/11/2013 | EP2635274A1 Anti-staphylococcal celecoxib derivatives |
| 09/11/2013 | CN103298811A Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists |
| 09/11/2013 | CN103298810A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 09/11/2013 | CN103298809A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
| 09/11/2013 | CN103298473A Therapeutic compositions for diabetic symmetrical polyneuropathy |
| 09/11/2013 | CN103298468A Ring-fused heterocyclic derivative |
| 09/11/2013 | CN103288827A Preparation method and activity of novel indole quinazoline alkaloid |
| 09/11/2013 | CN103288826A Alkaloid component in Nigella glandulifera Freyn seeds as well as preparation method and use thereof |
| 09/11/2013 | CN103288825A Organic semiconductor material containing phenanthroline and preparation method and application thereof |
| 09/11/2013 | CN103288824A Tetrahydropyridopyridone derivative as well as preparation method and application thereof |
| 09/11/2013 | CN103288823A N,N'-aryl substituted urea compound and application thereof |
| 09/11/2013 | CN102443003B Electron transport material for organic electroluminescent devices and preparation method of electron transport material |
| 09/11/2013 | CN102086211B Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 09/11/2013 | CN102070632B Pyridoimidazole derivatives and application thereof in organic light-emitting devices (OLEDs) |
| 09/11/2013 | CN101815713B Polycyclic compound |
| 09/11/2013 | CN101365676B Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 09/11/2013 | CN101151255B 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 09/10/2013 | US8530661 Process for the manufacture of pharmaceutically active compounds |
| 09/10/2013 | US8530660 Carboxamide-substituted dyes for analytical applications |
| 09/10/2013 | US8530648 Diaza-spiro[5.5]undecanes |
| 09/10/2013 | US8530487 Compounds useful for treating disorders related to TRPA1 |
| 09/10/2013 | US8530483 Substituted azabenzoxazoles |
| 09/10/2013 | US8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 |
| 09/10/2013 | US8529796 Charge transport compositions and electronic devices made with such compositions |
| 09/10/2013 | CA2747420C Azaazulene compounds |
| 09/10/2013 | CA2673254C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 09/10/2013 | CA2585934C Novel pyrazolopyridine urea kinase inhibitors |
| 09/06/2013 | WO2013130976A1 Serine/threonine kinase inhibitors |
| 09/06/2013 | WO2013130890A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors |
| 09/06/2013 | WO2013130855A1 Indazole derivatives |
| 09/06/2013 | WO2013130660A1 Amides as pim inhibitors |
| 09/06/2013 | WO2013130402A1 N- (5s, 6s, 9r) - 5 -amino- 6 - (2, 3 - difluorophenyl) -6, 7, 8, 9 - tetrahydro - 5h - cyclohepta [b] pyridin-9 -yl- 4 - (2 - oxo-2, 3 - dihydro - 1h- imidazo [4, 5 -b] pyridin - 1 - yl) piperidine - 1 - carboxylate, hemisulfate salt |
| 09/06/2013 | WO2013128465A1 Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof |
| 09/06/2013 | WO2013127268A1 Amido-benzyl sulfone and sulfonamide derivatives |
| 09/06/2013 | WO2013127267A1 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
| 09/06/2013 | WO2013127266A1 Amido-benzyl sulfone and sulfoxide derivatives |
| 09/05/2013 | US20130231604 Halogenated compounds for photodynamic therapy |
| 09/05/2013 | US20130231519 1H-Pyrrolo[2,3 b]pyridine derivatives |
| 09/05/2013 | US20130231518 Compounds and compositions for mitigating tissue damage and lethality |
| 09/05/2013 | US20130231481 Selective bromination of perylene diimides and derivatives thereof under mild conditions |
| 09/05/2013 | US20130231477 Novel method of preparing benzoimidazole derivatives |
| 09/05/2013 | US20130231363 Alternative forms of the phosphodiesterase-4 inhibitor n-cyclopropyl-1--4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide |
| 09/05/2013 | US20130231360 Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases |
| 09/05/2013 | US20130231358 Piperidinone carboxamide indane cgrp receptor antagonists |
| 09/05/2013 | US20130231354 Substituted azaindazole compounds |
| 09/05/2013 | US20130231353 Pyrido- and pyrimidopyrimidine derivatives as anti-profilerative agents |
| 09/05/2013 | US20130231348 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS |
| 09/05/2013 | US20130231344 Compounds that modulate intracellular calcium |
| 09/05/2013 | US20130231337 Bicyclic Heteroaryl Compounds |
| 09/05/2013 | US20130231333 Estrogen receptor modulators and uses thereof |
| 09/05/2013 | US20130231324 Spiro bicyclic diamine derivatives as hiv attachment inhibitors |
| 09/05/2013 | US20130231321 2-substituted-ethynylthiazole derivatives and uses of same |
| 09/05/2013 | US20130230578 Lipidated immune response modifier compound compositions, formulations, and methods |
| 09/05/2013 | US20130230459 RADIOLABELLED mGluR2 PET LIGANDS |
| 09/04/2013 | EP2634187A1 Deuterated morphinane compounds |
| 09/04/2013 | EP2634186A1 Naphthyridine derivative |
| 09/04/2013 | EP2632925A1 N1/N2-LACTAM ACETYL-CoA CARBOXYLASE INHIBITORS |
| 09/04/2013 | EP2632924A1 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists |
| 09/04/2013 | EP2632923A1 Quinazoline derivatives |
| 09/04/2013 | EP2632468A1 Therapeutic compositions for diabetic symmetrical polyneuropathy |
| 09/04/2013 | EP2632465A1 Inhibitors of the renal outer medullary potassium channel |
| 09/04/2013 | EP2632461A1 Isoindolinone pde10 inhibitors |
| 09/04/2013 | EP2632268A2 Novel compounds that are erk inhibitors |
| 09/04/2013 | CN103283053A Perylene-based semiconductors and methods of preparation and use thereof |
| 09/04/2013 | CN103282366A Compounds for treating respiratory syncytial virus infections |
| 09/04/2013 | CN103282365A Crystalline (8S,9R)--fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt |
| 09/04/2013 | CN103282364A Imidazo [4, 5 -] quinolin- 2 -one compound and its use as pi3 kinase / MTOR dual inhibitor |
| 09/04/2013 | CN103282362A Hybrid cyclic libraries and screens thereof |
| 09/04/2013 | CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors |
| 09/04/2013 | CN103275106A Indole alkaloid adduct, and preparation method and application thereof in preparing anti-tumor drug |
| 09/04/2013 | CN103275078A Method for industrial production of moxifloxacin side chain |
| 09/04/2013 | CN103275077A Ruthenium complex and preparation method thereof and purpose of product as histone deacetylase inhibitor |
| 09/04/2013 | CN103275067A Inhibitors of histone deacetylase |
| 09/04/2013 | CN102066342B Quinoxalinedione derivatives |
| 09/04/2013 | CN101918405B 13a-(s) desoxytylophorinine derivatives, preparation method, pharmaceutical compositon and use thereof |
| 09/04/2013 | CN101824027B Polysubstituted tetrahydroquinoline derivative with optical activity and synthetic method and use thereof |